| Ytd | 10.16% | |
| 1y | 21.57% |
| Open | 86.66 | Prev Close | 86.41 | Low | 86.68 | High | 88.23 | Mkt Cap | 14.86B |
| Vol | 1.06M | Avg Vol | 1.03M | EPS | 8.25 | P/E | 10.58 | Forward P/E | 12.08 |
| Beta | 0.70 | Short Ratio | 5.26 | Inst. Own | 75.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 88.41 | 200-d Avg | 78.07 | 1yr Est | 94.31 |
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combi
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks E
NeurAxis (NASDAQ: NRXS - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) are both heal
Tandem Diabetes Care (NASDAQ: TNDM - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) a
Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x a
Tidal Investments LLC trimmed its position in Solventum Corporation (NYSE: SOLV) by 25.0% in the und
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Solventum (SOLV) reported earnings 30 days ago. What's next for the stock?
EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management w
Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 20
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have been given an average recommenda
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS mo
SOLV Energy NASDAQ: MWH reported record first-half results for 2026, citing increased new-constructi
UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target
Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises t
Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the
Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the pr
Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target f
BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price targe
Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Informatio
Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensu
BMO Capital initiates coverage on Solventum (NYSE:SOLV) with a Market Perform rating and announces
Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade
Discover last week's top 10 large-cap stock gainers, why they rallied, and what catalysts drove
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Re
At close: October 9 at 4:00:00 PM EDT ...
As of 1:30:04 PM EDT. Market Open. What are the terms of XNDU COO Rafal Janik's share plan? What's b
The technical indicators for SOLV Energy are in a Strong Sell position based on daily analysis, with
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten
Ripple’s expansion into Wall Street financing is putting a familiar concern for XRP holders back int
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insi